Terms: = Lung cancer AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8
49 results:
1. [Expression of fat1 in lung Adenocarcinoma and Its Relationship
with Immune Cell Infiltration].
Ding C; Zhao W; Huang H; Li Y; Zhang Z; Zhang R; Wang Y; Wu D; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2024 Feb; 27(2):109-117. PubMed ID: 38453442
[TBL] [Abstract] [Full Text] [Related]
2. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.
Liu Q; Zhang J; Guo C; Wang M; Wang C; Yan Y; Sun L; Wang D; Zhang L; Yu H; Hou L; Wu C; Zhu Y; Jiang G; Zhu H; Zhou Y; Fang S; Zhang T; Hu L; Li J; Liu Y; Zhang H; Zhang B; Ding L; Robles AI; Rodriguez H; Gao D; Ji H; Zhou H; Zhang P
Cell; 2024 Jan; 187(1):184-203.e28. PubMed ID: 38181741
[TBL] [Abstract] [Full Text] [Related]
3. Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts.
Zhang L; Wang Y; Wang L; Wang M; Li S; He J; Ji J; Li K; Cao L
J Mol Med (Berl); 2024 Jan; 102(1):69-79. PubMed ID: 37978056
[TBL] [Abstract] [Full Text] [Related]
4. Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes.
Adler N; Bahcheli AT; Cheng KCL; Al-Zahrani KN; Slobodyanyuk M; Pellegrina D; Schramek D; Reimand J
Sci Adv; 2023 Nov; 9(44):eadh3083. PubMed ID: 37922356
[TBL] [Abstract] [Full Text] [Related]
5. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
[TBL] [Abstract] [Full Text] [Related]
6. Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data.
Li M; Gao X; Wang X
Front Immunol; 2023; 14():1090838. PubMed ID: 36911742
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer.
Xu F; Cui WQ; Liu C; Feng F; Liu R; Zhang J; Sun CG
FEBS Open Bio; 2023 Jan; 13(1):72-88. PubMed ID: 36282125
[TBL] [Abstract] [Full Text] [Related]
8. Molecular and Clinicopathological Characteristics of lung cancer Concomitant Chronic Obstructive Pulmonary Disease (COPD).
Ma H; Zhang Q; Zhao Y; Zhang Y; Zhang J; Chen G; Tan Y; Zhang Q; Duan Q; Sun T; Qi C; Li F
Int J Chron Obstruct Pulmon Dis; 2022; 17():1601-1612. PubMed ID: 35860812
[TBL] [Abstract] [Full Text] [Related]
9. Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population.
Huang Q; Zhou Y; Wang B; Zhao Y; Zhang F; Ding B
BMC Med Genomics; 2022 Jul; 15(1):146. PubMed ID: 35778737
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell lung cancer.
Feng Z; Yin Y; Liu B; Zheng Y; Shi D; Zhang H; Qin J
Cancer Control; 2022; 29():10732748221076682. PubMed ID: 35212236
[TBL] [Abstract] [Full Text] [Related]
11. Linc8087 predicts favorable prognosis and inhibits cell migration and invasion in NSCLC.
Qi Q; Chen C; Liu C; Zhang B; Ma Y; Zhang H; Huang W; Wang C
Pathol Res Pract; 2021 Sep; 225():153569. PubMed ID: 34391179
[TBL] [Abstract] [Full Text] [Related]
12. fat1 suppresses the tumor-initiating ability of nonsmall cell lung cancer cells by promoting Yes-associated protein 1 nuclear-cytoplasmic translocation.
Li M; Zhong Y; Wang M
Environ Toxicol; 2021 Nov; 36(11):2333-2341. PubMed ID: 34390292
[TBL] [Abstract] [Full Text] [Related]
13. lung but not brain cancer cell malignancy inhibited by commonly used anesthetic propofol during surgery: Implication of reducing cancer recurrence risk.
Hu C; Iwasaki M; Liu Z; Wang B; Li X; Lin H; Li J; Li JV; Lian Q; Ma D
J Adv Res; 2021 Jul; 31():1-12. PubMed ID: 34194828
[TBL] [Abstract] [Full Text] [Related]
14. The Proteomic Landscape of Growth Factor Signaling Networks Associated with
Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z
Cancer Res; 2021 Sep; 81(17):4402-4416. PubMed ID: 34167951
[TBL] [Abstract] [Full Text] [Related]
15. Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options.
Modesto A; Siegfried A; Lusque A; Vergez S; Sarini J; Brouchet L; Uro-Coste E; Graff-Cailleaud P; Delord JP
Curr Oncol; 2021 Apr; 28(3):1673-1680. PubMed ID: 33947015
[TBL] [Abstract] [Full Text] [Related]
16. fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis.
Pastushenko I; Mauri F; Song Y; de Cock F; Meeusen B; Swedlund B; Impens F; Van Haver D; Opitz M; Thery M; Bareche Y; Lapouge G; Vermeersch M; Van Eycke YR; Balsat C; Decaestecker C; Sokolow Y; Hassid S; Perez-Bustillo A; Agreda-Moreno B; Rios-Buceta L; Jaen P; Redondo P; Sieira-Gil R; Millan-Cayetano JF; Sanmatrtin O; D'Haene N; Moers V; Rozzi M; Blondeau J; Lemaire S; Scozzaro S; Janssens V; De Troya M; Dubois C; Pérez-Morga D; Salmon I; Sotiriou C; Helmbacher F; Blanpain C
Nature; 2021 Jan; 589(7842):448-455. PubMed ID: 33328637
[TBL] [Abstract] [Full Text] [Related]
17. PDL1 high expression without TP53, KEAP1 and EPHA5 mutations could better predict survival for patients with NSCLC receiving atezolizumab.
Wang H; Shan Q; Guo J; Han X; Zhao C; Li H; Wang Z
Lung Cancer; 2021 Jan; 151():76-83. PubMed ID: 33246647
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.
Shang Y; Li X; Liu W; Shi X; Yuan S; Huo R; Fang G; Han X; Zhang J; Wang K; Dou Z; Zhang Y; Zang A; Zhang L
Sci Rep; 2020 Nov; 10(1):20243. PubMed ID: 33219256
[TBL] [Abstract] [Full Text] [Related]
19. The combination of camrelizumab and apatinib obtained ongoing partial remission for a patient with osimertinib-resistant non-small cell lung cancer: case report.
Cong X; Chen J; Zheng W
Ann Palliat Med; 2021 Mar; 10(3):3469-3474. PubMed ID: 33040541
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathologic features and genomic analysis of pulmonary blastomatoid carcinosarcoma.
Zhao J; Xiang C; Zhao R; Guo P; Zheng J; Han-Zhang H; Yu K; Zhang J; Han Y
BMC Cancer; 2020 Mar; 20(1):248. PubMed ID: 32209061
[TBL] [Abstract] [Full Text] [Related]
[Next]
